Clariant to launch eight new high-performing excipients at the CPHI Milan 2024
Clariant is launching high-performing pharmaceutical ingredients to support the evolution of safe and effective medicines
Clariant is launching high-performing pharmaceutical ingredients to support the evolution of safe and effective medicines
Sun Pharma will have the exclusive worldwide rights to commercialise Fibromun
The authorization of bortezomib will enhance the company’s ability to deliver advanced cancer solutions in Southeast Asia
Developed in consultation with clinicians and patients for an enhanced user experience
India has taken the lead in recognising NAFLD as a major non-communicable disease
India called for stronger investments in health and social equity at G20 Joint Finance-Health Task Force Meeting
The company will also share results in two additional posters for deuruxolitinib
Apulki Healthcare is India's first PPP dedicated for cancer and cardiac care hospita
AMR poses a critical threat to global public health undermining decades of progress made in the field of modern medicine
Subscribe To Our Newsletter & Stay Updated